For research use only. We do not sell to patients.
Onartuzumab
CAS No. : 1133766-06-9
Biological Activity：Onartuzumab (MetMAb) is a unique, humanized and affinity-matured monovalent (one-armed) monoclonal antibody against the MET receptor. Onartuzumab potently inhibits HGF binding and receptor phosphorylation and signaling. Onartuzumab has antibody-like pharmacokinetics and antitumor activity.
Research Area：Cancer
Targets：c-Met/HGFR
Related Small Molecules:AMG-208;D6808;MET kinase-IN-2;c-Met-IN-9;Tyrosine kinase-IN-4;Savolitinib;Foretinib;PF-04217903 phenolsulfonate;MK-2461;XL092;SAR125844;MK-8033 hydrochloride;BPI-9016M;Ficlatuzumab;Meleagrin;c-Met inhibitor 1;Pamufetinib;PHA-665752;c-Met/HDAC-IN-2;SU11274;Antitumor agent-45;Capmatinib hydrochloride;SCR-1481B1;SYN1143;Amuvatinib hydrochloride;c-Met/HDAC-IN-3;Gemnelatinib
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
